These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16299277)

  • 1. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.
    Earnhart CG; Buckles EL; Dumler JS; Marconi RT
    Infect Immun; 2005 Dec; 73(12):7869-77. PubMed ID: 16299277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.
    Buckles EL; Earnhart CG; Marconi RT
    Clin Vaccine Immunol; 2006 Oct; 13(10):1162-5. PubMed ID: 17028218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
    Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
    Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
    Yang X; Li Y; Dunn JJ; Luft BJ
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
    Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
    Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.
    Earnhart CG; Buckles EL; Marconi RT
    Vaccine; 2007 Jan; 25(3):466-80. PubMed ID: 16996663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
    Baum E; Randall AZ; Zeller M; Barbour AG
    PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice.
    Krupka M; Masek J; Barkocziova L; Turanek Knotigova P; Kulich P; Plockova J; Lukac R; Bartheldyova E; Koudelka S; Chaloupkova R; Sebela M; Zyka D; Droz L; Effenberg R; Ledvina M; Miller AD; Turanek J; Raska M
    PLoS One; 2016; 11(2):e0148497. PubMed ID: 26848589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
    Jobe DA; Lovrich SD; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an ospC operator critical for immune evasion of Borrelia burgdorferi.
    Xu Q; McShan K; Liang FT
    Mol Microbiol; 2007 Apr; 64(1):220-31. PubMed ID: 17376084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.
    Lovrich SD; La Fleur RL; Jobe DA; Johnson JC; Asp KE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2007 May; 14(5):635-7. PubMed ID: 17344346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B; Freer H; Rollins A; Erb HN
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
    Jobe DA; Lovrich SD; Asp KE; Mathiason MA; Albrecht SE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2008 Jun; 15(6):981-5. PubMed ID: 18417666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages.
    Carrasco SE; Troxell B; Yang Y; Brandt SL; Li H; Sandusky GE; Condon KW; Serezani CH; Yang XF
    Infect Immun; 2015 Dec; 83(12):4848-60. PubMed ID: 26438793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.